How cannabis-related psychosis progresses from intoxication to schizophrenia through the DSM-5 lens

Using DSM-5 diagnostic categories, this review maps the cannabis-psychosis relationship along a continuum from cannabis intoxication to cannabis-induced psychotic disorder to schizophrenia.

Pearson, Nathan T et al.·International journal of environmental research and public health·2019·Moderate EvidenceReview
RTHC-02221ReviewModerate Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Cannabis intoxication can produce transient psychotic symptoms. When symptoms meet severity and duration thresholds, the diagnosis becomes cannabis-induced psychotic disorder, which in turn is heavily associated with future schizophrenia diagnoses. The review organizes diverse evidence into this clinical framework.

Key Numbers

Cannabis-induced psychotic disorder is "heavily associated" with future schizophrenia diagnoses. The exact conversion rates varied across cited studies.

How They Did This

Narrative review examining experimental studies, epidemiological data, and case series, organized by DSM-5 diagnostic categories.

Why This Research Matters

The cannabis-psychosis literature is overwhelming and fragmented. Organizing it by DSM-5 diagnoses helps clinicians understand where on the spectrum a given patient falls and what that might mean for prognosis.

The Bigger Picture

Understanding that cannabis-related psychosis exists on a continuum rather than as a binary may help with earlier identification and intervention for people at risk of progressing to schizophrenia.

What This Study Doesn't Tell Us

Narrative review, not systematic. The DSM-5 framework, while useful, may oversimplify the heterogeneity of psychotic experiences related to cannabis.

Questions This Raises

  • ?What predicts which individuals progress from cannabis-induced psychosis to schizophrenia?
  • ?Does cannabis cessation after a psychotic episode prevent progression?
  • ?Are high-potency products more likely to trigger progression along this continuum?

Trust & Context

Key Stat:
Cannabis-induced psychotic disorder strongly predicts future schizophrenia
Evidence Grade:
Moderate: narrative review integrating multiple evidence types, but not systematic.
Study Age:
Published in 2019.
Original Title:
Cannabis and Psychosis Through the Lens of DSM-5.
Published In:
International journal of environmental research and public health, 16(21) (2019)
Database ID:
RTHC-02221

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What is cannabis-induced psychotic disorder?

A DSM-5 diagnosis for psychotic symptoms (hallucinations, delusions) that develop during or shortly after cannabis use, last beyond the period of intoxication, and cause significant distress or impairment.

Does cannabis intoxication always lead to psychosis?

No. Transient psychotic symptoms during intoxication (paranoia, perceptual disturbances) are common but usually resolve. Only some individuals progress to a formal psychotic disorder diagnosis.

Read More on RethinkTHC

Cite This Study

RTHC-02221·https://rethinkthc.com/research/RTHC-02221

APA

Pearson, Nathan T; Berry, James H. (2019). Cannabis and Psychosis Through the Lens of DSM-5.. International journal of environmental research and public health, 16(21). https://doi.org/10.3390/ijerph16214149

MLA

Pearson, Nathan T, et al. "Cannabis and Psychosis Through the Lens of DSM-5.." International journal of environmental research and public health, 2019. https://doi.org/10.3390/ijerph16214149

RethinkTHC

RethinkTHC Research Database. "Cannabis and Psychosis Through the Lens of DSM-5." RTHC-02221. Retrieved from https://rethinkthc.com/research/pearson-2019-cannabis-and-psychosis-through

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.